Yayınlar & Eserler

Yayın Ağı
Makaleler 151
Tümü (151)
SCI-E, SSCI, AHCI (77)
SCI-E, SSCI, AHCI, ESCI (88)
ESCI (11)
Scopus (87)
TRDizin (33)
Diğer Yayınlar (39)

1. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

2. Does body mass index affect stem cell yield in healthy donors?

Yilmaz S., Okumus N., Seyhan M., Sahin R., Korkmaz G., ERKURT M. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

3. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

4. Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?

Katircilar Y., Sahin A., Aydin M. S., Erer K., ERKURT M. A., NAMDAROĞLU S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

5. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., Yilmaz S., Cagliyan G. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

6. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

7. The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes

Aslan Candir B., Okumus N., Hindilerden I. Y., ERKURT M. A., NAMDAROĞLU S., Merter M., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded) identifier identifier

8. Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

Karakus A., TOPTAŞ T., Dal M. S., Durdu A., Hatipoglu U., Kayer M. A., et al.
Bone Marrow Transplantation , cilt.60, sa.6, ss.864-872, 2025 (SCI-Expanded) identifier identifier

9. What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

Yigenoglu T. N., ERKURT M. A., Dagdas S., Ulu B. U., KUKU İ., Durdu A., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

10. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

11. Is there a relationship between vitamin D levels and graft versus host disease?

Yigenoglu T. N., Ulu B. U., NAMDAROĞLU S., ERKURT M. A., Sahin R., Okumus N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

12. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

13. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., Yigenoglu T. N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

14. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

15. Are mesenchymal stem cells still effective in acute GvHD management?

Ulu B. U., Hindilerden I. Y., Yigenoglu T. N., Tiryaki T. O., ERKURT M. A., Korkmaz G., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded) identifier identifier

16. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

Bakirtas M., Hindilerden I. Y., Ulu B. U., Ekinci O., Dogu M. H., Aydogdu I., et al.
Indian Journal of Hematology and Blood Transfusion , 2025 (SCI-Expanded) identifier

17. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
ACTA HAEMATOLOGICA POLONICA , cilt.55, 2024 (Scopus) identifier

18. Effects of extracorporeal photopheresis on survival in chronic graft versus host disease

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
MARMARA MEDICAL JOURNAL , cilt.37, 2024 (ESCI) identifier

19. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.
Journal of Current Hematology & Oncology Research , cilt.2, 2024 (Hakemli Dergi)

20. Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?

KAYA A., BERBER İ., KAYA E., ERKURT M. A., BİÇİM S., ARSLAN S., et al.
IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI) identifier

21. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

ERYILDIZ S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ.
Journal of Current Hematology & Oncology Research , cilt.2, 2024 (Hakemli Dergi)

22. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.
IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI) Creative Commons License identifier

23. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience

Uysal A., ERKURT M. A., KUKU I., Kaya E., BERBER I., SARICI A., et al.
ACTA ONCOLOGICA TURCICA , cilt.56, sa.2, ss.106-113, 2023 (Hakemli Dergi) Creative Commons License identifier

24. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.
İstanbul Medical Journal , cilt.24, sa.2, ss.216-220, 2023 (Hakemli Dergi) identifier

25. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

SERİN İ., DOĞU M., EKINCI O., ÇAĞLIYAN G. A., BAŞTÜRK A., ARAS M. R., et al.
İstanbul Medical Journal , cilt.24, sa.2, ss.120-125, 2023 (Hakemli Dergi) identifier

26. The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Annals of Medical Research , cilt.30, sa.3, ss.331-336, 2023 (Hakemli Dergi) identifier

27. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.
Fırat Tıp Dergisi , cilt.28, sa.1, ss.46-50, 2023 (Hakemli Dergi) identifier

28. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , cilt.1, 2023 (Hakemli Dergi) Creative Commons License

29. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
MARMARA MEDICAL JOURNAL , cilt.36, 2023 (ESCI) Creative Commons License identifier

30. The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
IRAQI JOURNAL OF HEMATOLOGY , cilt.11, sa.2, ss.110-117, 2022 (Hakemli Dergi)

31. Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients

BERBER İ., KIRICI BERBER N., SARICI A., GÖZÜKARA BAĞ H. G., BİÇİM S., TURGUT B., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.4, ss.1183-1189, 2022 (Hakemli Dergi)

32. Effects Of Ethnicity On Allogenic Stem Cell Mobilization

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
International Journal of Clinical Images and Medical Reviews , cilt.2, sa.2, ss.1-4, 2022 (Hakemli Dergi)

33. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.
Medicine Science , cilt.11, sa.2, ss.920-923, 2022 (Hakemli Dergi) identifier

34. Calreticulin Mutations in Philadelphia Chromosome Negative Myeloproliferative Neoplasms

Gulbay G., Bag H. G. G., yesilada e., ERKURT M. A.
Uluslararası Hematoloji-Onkoloji Dergisi , cilt.32, sa.2, ss.75-80, 2022 (SCI-Expanded) Creative Commons License identifier

35. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., Dal M. S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded) identifier identifier

36. The effect of comorbidity on survival and collected CD34+cell counts in autologous hematopoietic stem cell transplant patients

SARICI A., ERKURT M. A., KUKU İ., Bahcecioglu O. F., Bicim S., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.61, sa.1, 2022 (SCI-Expanded) identifier identifier

37. The effect of vitamin d and parathyroid hormone level on the number of cd 34 stem cells after mobilization regime in patients with multiple myelom and non hodgkin lymphoma

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
International Journal of Clinical Images and Medical Reviews , cilt.1, sa.1, ss.1-3, 2022 (Hakemli Dergi) Creative Commons License

38. Non-infectious Complications in Patients with Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern Anatolia

KARAMAN S., SARICI A., ERKURT M. A., BİÇİM S., HİDAYET E., KAYA A., et al.
ACTA ONCOLOGICA TURCICA , cilt.55, 2022 (Hakemli Dergi) identifier

39. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.
INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

40. The effect of cryopreserved and noncryopreserved stem cells on the outcome of autologous stem-cell transplantation in multiple myeloma patients: A single-center experience

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
EGYPTIAN JOURNAL OF HAEMATOLOGY , cilt.47, 2022 (Hakemli Dergi)

41. Psychological well-being in patients undergoing stem cell transplantation

Bayir B., AYLAZ R., ERKURT M. A., Bostanci S.
ACTA SCIENTIARUM-HEALTH SCIENCES , cilt.44, ss.1-9, 2022 (ESCI) Sürdürülebilir Kalkınma identifier

42. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids

KAYA A., KUKU İ., ERKURT M. A., KAYA E., BERBER İ., SARICI A., et al.
International Journal of Research and Reports in Hematology , cilt.5, sa.1, ss.27-33, 2022 (Hakemli Dergi)

43. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

BİÇİM S., BERBER İ., ERKURT M. A., KUKU İ., KAYA E., BİLGİÇ Y., et al.
International Journal of Research and Reports in Hematology , cilt.5, sa.2, ss.1-5, 2022 (Hakemli Dergi)

44. Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

HİDAYET E., ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., et al.
Medicine Science , cilt.11, 2022 (Hakemli Dergi) identifier

45. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.
International Journal of Research and Reports in Hematology , cilt.4, sa.2, 2021 (Hakemli Dergi)

46. Life saving effect of early use of convalescent plasma in Covid-19 treatment

SARICI A., ERKURT M. A., KUKU İ., BİÇİM S., BERBER İ., KAYA E., et al.
Annals of Medical Research , cilt.28, sa.12, ss.2242-2247, 2021 (Hakemli Dergi) identifier

47. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.
Annals of Medical Research , cilt.28, sa.11, ss.2065-2070, 2021 (Hakemli Dergi) identifier

48. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients

ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

49. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Dal Sinan M., Batgi H., ERKURT M. A., Hindilerden I. Y., KUKU İ., Kurtoglu E., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

50. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis

BERBER İ., Cagin Y. F., ERDOĞAN M. A., Ataman E., GÖZÜKARA BAĞ H. G., ERKURT M. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

51. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study

SARICI A., ERKURT M. A., KUKU İ., Gok S., Bahcecioglu O. F., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

52. An innovation in stem cell harvesting: Heparin use

GÜL H. G., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

53. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., Korkmaz S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

54. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience

Batgi H., Dal M. S., ERKURT M. A., KUKU İ., Kurtoglu E., Hindilerden I. Y., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

55. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

Basturk A., Sayin S., ERKURT M. A., SARICI A., Ekinci O., Kum A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

56. Apheresis in patients with sepsis: A multicenter retrospective study

Aydin K., Korkmaz S., ERKURT M. A., SARICI A., Ekinci O., Baysal N. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

57. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients

SARICI A., ERKURT M. A., Bahcecioglu O. F., Gok S., KUKU İ., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded) identifier identifier

58. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma-Single center experience

SARICI A., ERKURT M. A., Bahcecioglu O. F., Bicim S., BERBER İ., Gok S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded) identifier identifier

59. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

Goren Sahin D., Akay O. M., KEKLİK M., Okan V., KARAKUŞ A., Demir C., et al.
ANNALS OF HEMATOLOGY , cilt.100, sa.7, ss.1667-1675, 2021 (SCI-Expanded) identifier identifier

60. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

SARICI A., ERKURT M. A., KUKU İ., Gök S., Bahçecioğlu Ö. F., BİÇİM S., et al.
Medical Science and Discovery , cilt.8, sa.6, ss.356-360, 2021 (Hakemli Dergi)

61. Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement

SARICI A., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BİÇİM S., et al.
Medicine Science , cilt.10, sa.4, ss.1542-1545, 2021 (Hakemli Dergi) identifier

62. COVID-19 in hematopoietic cell transplant recipients

Altuntas F., Ata N., Yigenoglu T. N., Basci S., Dal M. S., Korkmaz S., et al.
BONE MARROW TRANSPLANTATION , cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

63. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

SARICI A., ERKURT M. A., KUKU İ., BAHÇECİOĞLU Ö. F., GÖK S., BİÇİM S., et al.
Medicine Science , cilt.10, sa.4, ss.1133-1137, 2021 (Hakemli Dergi) identifier

64. BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience

DEVİREN M. V., SARICI A., ERKURT M. A., BAHÇECİOĞLU Ö. F., BİÇİM S., BERBER İ., et al.
Medicine Science , cilt.10, sa.3, ss.856-859, 2021 (Hakemli Dergi)

65. The outcome of COVID-19 in patients with hematological malignancy

Yigenoglu T. N., Ata N., Altuntas F., Basci S., Dal M. S., Korkmaz S., et al.
JOURNAL OF MEDICAL VIROLOGY , cilt.93, sa.2, ss.1099-1104, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

66. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.
Annals of Medical Research , cilt.28, sa.10, ss.1824-1829, 2021 (Hakemli Dergi) identifier

67. Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., et al.
Annals of Medical Research , cilt.28, sa.12, ss.2239-2241, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

68. COVID-19 clinical course and blood groups: Turkish population-based study

DAL M. S., Ata N., Altuntas F., Basci S., Yigenoglu T. N., Korkmaz S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

69. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

70. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

ERKURT M. A., SARICI A., BERBER İ., KUKU İ., KAYA E., Ozgul M.
TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.5, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

71. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption

Yigenoglu T. N., Ulas T., Dal M. S., Korkmaz S., ERKURT M. A., Altuntas F.
TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.4, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

72. Convalescent plasma therapy in patients withCOVID-19

Yigenoglu T. N., HACIBEKİROĞLU T., BERBER İ., Dal M. S., BAŞTÜRK A., Namdaroglu S., et al.
JOURNAL OF CLINICAL APHERESIS , cilt.35, sa.4, ss.367-373, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier identifier

73. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.4, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

74. Türkiye’xxnin doğusunda non-Hodgkin lenfoma hastalarının klinik ve patolojik özellikleri

DOGAN A., YILDIRIM D. N., ERKURT M. A., EKİNCİ Ö., KUKU İ., KAYA E.
CUKUROVA MEDICAL JOURNAL , cilt.45, sa.2, ss.533-540, 2020 (ESCI)

75. Clinical and pathological characteristics of patients with non-Hodgkin lymphoma cases in Eastern Turkey

Dogan A., Dogan N. Y., ERKURT M. A., Ekinci O., KUKU İ., KAYA E.
CUKUROVA MEDICAL JOURNAL , cilt.45, sa.2, ss.533-540, 2020 (ESCI) identifier

76. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Okay M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded) identifier identifier identifier

77. The Evaluation of Common Chromosomal Rearrangements and Their Frequencies in Adult Acute Myeloid Leukemia Cases in Malatya Province of Turkey

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G.
Eastern Journal Of Medicine , cilt.25, sa.3, ss.350-355, 2020 (Scopus)

78. Repeat Ultrasonographic Examinations Reveal Accessory Spleen in a Case with Relapse ITP

SARICI A., SLOCUM A., ULUBABA H. E., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.
International Journal of Blood Research and Disorders , cilt.6, sa.1, ss.1-3, 2019 (Hakemli Dergi)

79. Evaluation of the JAK2 V617F gene mutation in myeloproliferative neoplasms cases: a one-center study from Eastern Anatolia

Gülbay G., YEŞİLADA E., ERKURT M. A., BAG H. G., KUKU İ., KAYA E.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.44, sa.4, ss.492-498, 2019 (SCI-Expanded) identifier identifier

80. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S. K., Dadin S. A., ÇAĞLIYAN G. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.3, ss.287-292, 2019 (SCI-Expanded) identifier identifier identifier

81. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study

Ciftciler R., Sevindik O. G., Tekgunduz A. I. E., ERKURT M. A., VURAL F., TURGUT B., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.3, ss.169-177, 2019 (SCI-Expanded) identifier identifier identifier

82. Repeat ultrasonographic examinations reveal accessory spleen in case with relapse ITP

SARICI A., SLOCUM A., ER ULUBABA H., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.
International journal of blood research and disorders , cilt.6, sa.1, ss.1-3, 2019 (Hakemli Dergi)

83. Stem cell mobilization kinetics in elderly patients with multiple myeloma

Dogu M. H., Batgi H., ERKURT M. A., Hacioglu S., Tekgunduz E., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.2, ss.204-207, 2018 (SCI-Expanded) identifier identifier identifier

84. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., Kaya A. H., KAYNAR L., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.1, ss.27-30, 2018 (SCI-Expanded) identifier identifier identifier

85. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma

Dogu M. H., Cagirgan S., Ocakci S., Kaya A. H., Ilkkilic K., Sanli N. M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.6, ss.814-818, 2017 (SCI-Expanded) identifier identifier identifier

86. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)

Tekgunduz E., Arat M., GÖKER H., Ozdogu H., KAYNAR L., Cagirgan S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.6, ss.845-849, 2017 (SCI-Expanded) identifier identifier identifier

87. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Tekgunduz E., DEMİRKAN F., VURAL F., GÖKER H., Ozdogu H., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.6, ss.804-808, 2017 (SCI-Expanded) identifier identifier identifier

88. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

BİLGİÇ Y., AKBULUT A. S., Kutlu O., ÇOLAK C., Yilmaz C., SEÇKİN Y., et al.
International Journal of Clinical and Experimental Medicine , cilt.9, sa.7, ss.13918-13925, 2016 (SCI-Expanded) identifier

89. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters

Koroglu M., ERKURT M. A., KUKU İ., KAYA E., Berber İ., Nizam I., et al.
MEDICAL SCIENCE MONITOR , cilt.22, ss.1329-1333, 2016 (SCI-Expanded) identifier identifier identifier

90. Leukapheresis Treatment in Elderly Acute Leukemia Patients with Hyperleukocytosis: A Single Center Experience

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., Bag H. G., NIZAM I., et al.
JOURNAL OF CLINICAL APHERESIS , cilt.31, sa.1, ss.53-58, 2016 (SCI-Expanded) identifier identifier identifier

91. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

BERBER İ., ERKURT M. A., KUKU İ., Maya E., Bag H. G., NIZAM I., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.48-52, 2016 (SCI-Expanded) identifier identifier identifier

92. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?

Dogu M. H., KAYA E., Berber İ., SARI İ., Tekgunduz E., ERKURT M. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.76-79, 2016 (SCI-Expanded) identifier identifier identifier

93. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study

ERKURT M. A., Berber İ., Tekgunduz E., Dogu M. H., Korkmaz S., Demir C., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.80-84, 2016 (SCI-Expanded) identifier identifier identifier

94. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

BİLGİÇ Y., AKBULUT A. S., KUTLU O., ÇOLAK C., YILMAZ C., SEÇKİN Y., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.13918-13925, 2016 (SCI-Expanded)

95. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.273-280, 2016 (SCI-Expanded) identifier identifier identifier

96. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

Bilgic Y., Akbulut S., Kutlu O., Colak C., Yilmaz C., Seckin Y., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.13918-13925, 2016 (SCI-Expanded) identifier identifier identifier

97. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience

BERBER İ., KUKU İ., ERKURT M. A., KAYA E., Bag H. G., NIZAM I., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.2, ss.185-190, 2015 (SCI-Expanded) identifier identifier identifier

98. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes

Dogu M. H., KEKLİK M., TERZİ H., KORKMAZ S., ERKURT M. A., Cagliyan G. A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.15, 2015 (SCI-Expanded) identifier

99. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange

ERKURT M. A., Berber İ., Berktas H. B., KUKU İ., KAYA E., Koroglu M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.52, sa.2, ss.194-198, 2015 (SCI-Expanded) identifier identifier identifier

100. Myocardial Infarction in a Splenectomized Patient with Immune Trombocytopenia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.
American Journal of Medical Case Reports , cilt.3, sa.9, ss.301-303, 2015 (Hakemli Dergi)

101. Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma despite Normal Coagulation Parameters

BERBER İ., ERKURT M. A., NİZAM İ., KUKU İ., KAYA E., ünlü s., et al.
American Journal of Medical Case Reports , cilt.3, sa.3, ss.82-84, 2015 (Hakemli Dergi)

102. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience

BERBER İ., ERKURT M. A., NIZAM I., KOROGLU M., KAYA E., KUKU İ., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16308-16314, 2015 (SCI-Expanded) identifier identifier identifier

103. CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORS AFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKIN LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY

Berber İ., ERKURT M. A., KEKLİK M., Dogu M. H., TERZİ H., Pala C., et al.
ACTA MEDICA MEDITERRANEA , cilt.31, sa.6, ss.1195-1202, 2015 (SCI-Expanded) identifier identifier

104. Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis A Very Rare Event

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.
American Journal of Medical Case Reports , cilt.3, sa.11, ss.372-373, 2015 (Hakemli Dergi)

105. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report

Berber İ., ERKURT M. A., KUKU İ., KAYA E., Unlu S., ERTEM K., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.1, ss.73-76, 2014 (SCI-Expanded) identifier identifier identifier

106. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation

BERBER İ., ERKURT M. A., KUKU İ., KAYA E.
American Journal of Medical Sciences And Medicine , 2014 (Hakemli Dergi)

107. As a Rare Disease Bernard Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura A Case Report

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , cilt.2, sa.5, ss.102-106, 2014 (Hakemli Dergi)

108. Atypical Presentation of Plasmacytoma

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , cilt.2, sa.4, ss.82-83, 2014 (Hakemli Dergi)

109. Acute Myeloid Leukemia Significance of the Skin Test

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , cilt.2, sa.3, ss.55-56, 2014 (Hakemli Dergi)

110. Etiologic Factors of Nonalcoholic Hepatosteathosis in Malatya

GÜNDÜZ E., BENTLİ R., ULUTAŞ Ö., BERBER İ., ERKURT M. A.
Journal of Turgut Ozal MEdicine Center , cilt.21, sa.2, ss.130-134, 2014 (Hakemli Dergi)

111. Aggressive Progression of Mantle Cell Lymphoma ACase Report

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.
American Journal of Medical Case Reports , cilt.2, sa.1, ss.30-31, 2014 (Hakemli Dergi)

112. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula

Berber İ., ERKURT M. A., KUKU İ., KAYA E., KUTLU R., Koroglu M., et al.
MEDICAL PRINCIPLES AND PRACTICE , cilt.23, sa.4, ss.380-383, 2014 (SCI-Expanded) identifier identifier identifier

113. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation Review Article

BERBER İ., ERKURT M. A., YETKİN F., KUKU İ., KAYA E., bodakcı e., et al.
American Journal of Medical Sciences and Medicine , cilt.2, sa.5, ss.85-88, 2014 (Hakemli Dergi)

114. Decitabine Induced Localized Maculopapular Eruption

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., NİZAM İ., KAYA E., et al.
British Journal of Medicine and Medical Research , cilt.4, sa.4, ss.1002-1007, 2014 (Hakemli Dergi)

115. Haploidentical Transplantation Experience in Turgut Ozal MedicalCenter Case Report and a Review of Literature

BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., BENTLİ R., et al.
Journal of Turgut Ozal Medicine , cilt.21, sa.1, ss.55-58, 2014 (Hakemli Dergi)

116. A Rare Disease in the Differential Diagnosis of Acute Pancreatitis: Acute Brucellosis

Berber İ., ERKURT M. A., YETKİN F., Unlu S., Yilmaz S., BENTLİ R., et al.
INTERNAL MEDICINE , cilt.53, sa.20, ss.2401-2404, 2014 (SCI-Expanded) identifier identifier identifier

117. Hermansky-Pudlak Syndrome: A Case Report

BERBER İ., ERKURT M. A., KUKU I., Kaya E., KOROGLU M., NIZAM I., et al.
CASE REPORTS IN HEMATOLOGY , cilt.2014, 2014 (ESCI) identifier identifier identifier

118. Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia.

BERBER I., DIRI H., ERKURT M. A., AYDOGDU I., Kaya E., KUKU I.
Advances in hematology , cilt.2014, ss.297057, 2014 (Scopus) Sürdürülebilir Kalkınma identifier identifier

119. Etiologic Evaluation of 1012 Patients Admitted with Thrombocytopenia

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KÖROĞLU M., KUKU İ., et al.
British Journal of Medicine and Medical Research , cilt.4, sa.1, ss.104-113, 2014 (Hakemli Dergi)

120. Donor Selection in Allogeneic Stem Cell Transplantation

ERKURT M. A., BERBER İ., KUKU İ., KAYA E., NİZAM İ.
American Journal of Clinical Medicine Research , cilt.2, sa.1, ss.32-35, 2014 (Hakemli Dergi)

121. Clinicopathological Characteristics of Pernicious Anemia A Study of 300 Patients in Turkey

BENTLİ R., BERBER İ., ERKURT M. A., AYDOĞDU İ., GÜNDÜZ E., NİZAM İ., et al.
British Journal of Medicine and Medical Research , cilt.4, sa.3, 2013 (Hakemli Dergi)

122. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report

Koroglu M., ERKURT M. A., Berber İ., KUKU İ., KAYA E., Ozkahraman A., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.341-344, 2013 (SCI-Expanded) identifier identifier identifier

123. Roles of CD5 CD19 CD41a CD55 and CD59 in Chronic Immune Thrombocytopenic Purpura ITP

kaya f., BERBER İ., ERKURT M. A., AYDOĞDU İ., REİSLİ İ.
British Journal of Medicine and Medical Research , cilt.4, sa.2, 2013 (Hakemli Dergi)

124. Familial Chronic Lymphocytic Leukemia Patients in Eastern Anatolia Region

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

125. Extranasal NK Cell Lymphoma with Extensive Skin Involvement A Case Report

ERKURT M. A., BERBER İ., KARADAĞ N., BENTLİ R., KAYA E., KÖROĞLU M., et al.
Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.276-278, 2013 (Hakemli Dergi)

126. Evans Seyndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

127. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

KAYA E., KEKLİK M., ŞENCAN M., Yilmaz M., Keskin A., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.349-352, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

128. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

ERKURT M. A., Kuku L., KAYA E., Ozgen U., Berber İ., Koroglu M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.335-339, 2013 (SCI-Expanded) identifier identifier identifier

129. A Rare Disease in Adult Langerhans Cell Histiocytosis

BERBER İ., ERKURT M. A., KUKU İ., KÖROĞLU M., KAYA E., ÜNLÜ S.
World Journal of Oncology , cilt.4, sa.3, ss.165-168, 2013 (ESCI) identifier

130. Double Hit Lymphoma Presenting with Aggressive Progression A CaseReport

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., KUKU İ.
Journal Of Turgut Ozal Medical Center , cilt.20, sa.1, ss.74-76, 2013 (Hakemli Dergi)

131. After allogenic bone marrow transplantation agent of hemorrhagic cystitis BK virus

BERBER İ., KÖROĞLU M., ERKURT M. A., OĞUZ F., ALTINTAŞ R., KAYA E., et al.
Case Reports in Clinical Medicine , cilt.2, sa.5, ss.298-301, 2013 (Hakemli Dergi)

132. Doğu Anadolu Bölgesindeki Ailesel Kronik Lenfositik Lösemili Hastalarımız

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

133. Burkitt s lymphoma presenting with rapidly and multi organ involvement A case presentation

BERBER İ., ERKURT M. A., KÖROĞLU M., KUKU İ., KAYA E., BENTLİ R.
Case Reports in Clinical Medicine , cilt.2, sa.04, ss.242-245, 2013 (Hakemli Dergi)

134. Pulmonary Embolism as the Initial Presentation of Testicular Carcinoma

BERBER İ., BENTLİ R., ERKURT M. A., ULUTAŞ Ö., EDİZ C., NİZAM İ., et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2013, 2013 (ESCI) Sürdürülebilir Kalkınma identifier identifier

135. Evans Syndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

136. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
American Journal of Medical Case Reports , 2013 (Hakemli Dergi)

137. An Uncommon Case of Acute Brucellosis Presenting with Severe Thrombocytopenia

Dal S. E., ERSOY Y., ERKURT M. A., YETKİN F., KUZUCU Ç., Akdogan O.
INTERNAL MEDICINE , cilt.51, sa.23, ss.3291-3293, 2012 (SCI-Expanded) identifier identifier identifier

138. Thrombocytopenia in Adults Review Article

ERKURT M. A., KAYA E., BERBER İ., KÖROĞLU M., KUKU İ.
Journal of Hematology , cilt.1, ss.44-53, 2012 (ESCI)

139. The levels of nitric oxide in megaloblastic anemia

ERKURT M. A., Aydogdu I., BAYRAKTAR N., KUKU İ., KAYA E.
TURKISH JOURNAL OF HEMATOLOGY , cilt.26, sa.4, ss.197-200, 2009 (SCI-Expanded) identifier identifier identifier

140. A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., MIZRAK B., BASARAN Y.
Cases journal , cilt.2, ss.8183, 2009 (Hakemli Dergi) identifier identifier

141. Nodular melanoma presenting with rapid progression and widespread metastases: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., BASARAN Y.
Journal of medical case reports , cilt.3, ss.50, 2009 (Scopus) identifier identifier

142. Kanser kemoterapisi ve böbrek

ERKURT M. A., KUKU İ., KAYA E., AYDOĞDU İ.
TURGUT ÖZAL TIP DERGİSİ , cilt.16, sa.1, ss.63-68, 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

143. Prevalence of Gallstones in Patients with Chronic Myelocytic Leukemia

Ates F., ERKURT M. A., KARINCAOĞLU M., ALADAĞ M., Aydogdu I.
MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.3, ss.175-179, 2009 (SCI-Expanded) identifier identifier identifier

144. Clinicopathologic Characteristics and Therapeutic Outcomes of Primary Gastrointestinal Non-Hodgkin's Lymphomas: 10 Years of Experience from a Single Center in Eastern Anatolia

ERKURT M. A., Aydogdu I., KUKU İ., KAYA E., Basaran Y.
MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.5, ss.399-406, 2009 (SCI-Expanded) identifier identifier identifier

145. Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study

KAYNAR L., Altuntas F., Aydogdu I., Turgut B., KOÇYİĞİT İ., Hacioglu S. K., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.38, sa.2, ss.109-115, 2008 (SCI-Expanded) identifier identifier identifier

146. Anticancer drug induced glomerular dysfunction

ERKURT M. A., AYDOĞDU İ., KUKU İ., KAYA E., ÖZHAN O.
World Journal of Medical Sciences , cilt.3, sa.1, ss.5-9, 2008 (Hakemli Dergi)

147. Effects of cyanocobalamin on immunity in patients with pernicious anemia

ERKURT M. A., AYDOGDU I., Dikilitas M., KUKU İ., KAYA E., BAYRAKTAR N., et al.
MEDICAL PRINCIPLES AND PRACTICE , cilt.17, sa.2, ss.131-135, 2008 (SCI-Expanded) identifier identifier identifier

148. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from eastern Anatolia

KAYA E., Erkurt M. A., Aydogdu I., Kuku I., Ozhan O., Oner R. I., et al.
MEDICAL PRINCIPLES AND PRACTICE , cilt.16, sa.2, ss.100-106, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

149. Bone relapse in a patient with acute lymphoblastic leukaemia.

AYDOGDU I., Erkurt A., Kaya E., KUKU I.
British journal of haematology , cilt.129, ss.163, 2005 (SCI-Expanded) identifier identifier

150. Hiperlökositozlu lösemi hastalarımızda terapötik ve proflaktik lökoferez Deneyimlerimiz

KUKU İ., KAYA E., ERKURT M. A., UZER E., ÖZGÜL M., DİKİLİTAŞ M., et al.
Turgut Özal Tıp Merkezi Dergisi , cilt.11, sa.4, ss.243-246, 2004 (Hakemli Dergi)

151. Malatya ve Çevresi ABO ve Rh Kan Grubu Dağılımı

KUKU İ., KAYA E., ERKURT M. A., DİKİLİTAŞ M., YILDIZ R., ORHAN M., et al.
Turgut Özal Tıp Merkezi Dergisi , cilt.11, sa.4, ss.213-215, 2004 (Hakemli Dergi) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 47

1. REFRAKTER KRONİK İTP’ DE DANAZOL TEDAVİSİ

ARSLAN S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A.
50. Ulusal Hematoloji Kongresi - 2024, 29 Ekim - 02 Kasım 2024, (Özet Bildiri)

2. İnönü University Turgut Özal Medical Center Red Crescent Pool Platelet Experience

HİDAYET E., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, İstanbul, Türkiye, 14 - 17 Eylül 2022, (Tam Metin Bildiri)

3. Philadelphia kromozomu negatif miyeloproliferatif neoplazilerinde kalretikülin mutasyonları

GÜLBAY G., GÖZÜKARA BAĞ H. G., YEŞİLADA E., ERKURT M. A.
XVII. Tıbbi Biyoloji ve Genetik Kongresi 28-31 Ekim 2021 Online, 28 Ekim 2021, cilt.52, ss.364-365, (Özet Bildiri)

4. Hemoglobin S Polimerizasyon İnhibitörü Voxelotor’un Orak Hücre Hastalığındaki Etkililiği ve Güvenliliği: Randomize Kontrollü Çalışmaların Sistematik Derlemesi ve Meta-Analizi

TANRIVERDİ L. H., SARICI A., PARLAKPINAR H., ERKURT M. A.
25. Ulusal Farmakoloji Kongresi, İzmir, Türkiye, 04 Kasım 2019, (Özet Bildiri)

5. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.219, (Özet Bildiri)

6. GRAFT VERSUS HOST HASTALIĞINDA İBRUTİNİBKULLANIMI: TEK MERKEZ DENEYİMİ

ÖZKAN S. G., KAYA E., ERKURT M. A., SARICI A., BERBER İ., KUKU İ.
45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)

7. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.254-255, (Özet Bildiri) identifier

8. Non-Hodgkin Lenfoma Hastalarının Klinik ve Patolojik Özellikleri: Tek Merkez Deneyimi.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.
44. Ulusal Hematoloji Kongresi., 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

9. Clinical and pathological characteristics of non-Hodgkin lymphoma patients in eastern Turkey: a single-center study.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.
IXth International Eurasian Hematology Oncology Congress., İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

10. Relation of basal vitamin D and parathyroid hormone levels to CD34 cell counts in multiple myeloma and lymphoma patients with stem cell mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
9th International Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, sa.1, ss.34-70, (Tam Metin Bildiri)

11. Relation of Basal Vitamin D and Parathyroid Hormone Levels to CD34+ Cell Counts in Multiple Myeloma and Lymphoma Patients with Stem Cell Mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
IX. International Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

12. Thrombocytapheresis decreases systolic blood pressure and increases sympatho-vagal balance

ERKURT M. A., KAYA E., KUKU İ., YILDIZ S.
9th International Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

13. Akut Myeloid Lösemili Olgularımızda T(15 17) PML-RARA, T(8 21) RUNX1-RUNX1T1, inv 16 CBFB-MYH11A ve t(9 22) BCR-ABL1 Pozitifliğinin Araştırılması

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.
V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Türkiye, 27 - 29 Nisan 2018, (Özet Bildiri)

14. Philadelphia Kromozomu Negatif Hastalarda JAK2 V617F Gen Mutasyonunun Değerlendirilmesi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.
V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Türkiye, 27 - 29 Nisan 2018, (Özet Bildiri)

15. Türk Hastalarda Jak2 V617f Gen Mutasyonunun Değerlendirilmesi: Doğu Anadolu’xxdan Tek Merkez Deneyimi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KUKU İ., KAYA E.
I. Hematolojik Nadir Hastalıklar Kongresi, Girne, Kıbrıs (Kktc), 8 - 10 Şubat 2018, ss.40, (Özet Bildiri)

16. myokard infarktüsü ile prezente olan izole trombositozlu kronik myeloid lösemi: olgu sunumu

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.
43.Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

17. MYELOM SEYRİNDE ASİT OLUŞUMU

ÖZKAN M., KUŞCU A., KUKU İ., KAYA E., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

18. BORTEZOMİB İLİŞKİLİ İŞİTME KAYBI

ÖZKAN M., ÖZEN İ. N., KUKU İ., KAYA E., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

19. MİYOKARD İNFARKTÜSÜ İLE PREZENTE OLAN İZOLETROMBOSİTOZLU KRONİK MYELOİD LÖSEMİ:OLGU SUNUMU

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

20. Mean corpuscular volüme can be early predictor for molecular response in chronic phase chronic myeloid leukemia patients

ÖZKAN M., KAYA E., CIRIK S., KUKU İ., ERKURT M. A.
VIII. International Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, sa.1, ss.52, (Özet Bildiri)

21. Myeloid Sarcoma of the Tongue with Myelodysplastic Syndrome: A Case Report

CIRIK S., ÖZKAN M., KUKU İ., KAYA E., ERKURT M. A.
4th Aegean Hematology Oncology Congress, 21 - 24 Eylül 2017, (Özet Bildiri)

22. Bortezomib Associated Hearing Loss

ÖZKAN M., KAYA E., ERKURT M. A., KUKU İ.
4Th Aegean Hematology Oncology Congress, 21 - 24 Eylül 2017, (Özet Bildiri)

23. Bortezomib associated hearing loss

ÖZKAN M. C., ÖZEN İ. N., KUKU İ., KAYA E., ERKURT M. A.
4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017, (Tam Metin Bildiri)

24. A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 Study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., KAYA E., KAYNAR L., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri) identifier

25. THE TROUBLE THAT HEMATOLOGISTS DEALING WITH: VARICELLA-ZOSTER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

ÖZKAN M., OZEN I. N., DOLASIK I., KAYA E., ERKURT M. A., KUKU İ.
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.864, (Özet Bildiri) identifier

26. POSTTRANSPLANT 5q del SAPTANAN AKUT LENFOBLASTİK LÖSEMİ OLGUSU

ÖZKAN M., NİZAM İ., DOLAŞIK İ., KUKU İ., KAYA E., ERKURT M. A.
2. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Türkiye, 18 - 20 Mart 2016, (Özet Bildiri)

27. BİLİNÇ BULANIKLIĞI İLE ORTAYA ÇIKAN SANTRAL SİNİR SİSTEMİNDE İNVASİF ASPERGİLLÜS ENFEKSİYONU

NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., ÖZKAN M., DOLAŞIK İ., et al.
2.EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Türkiye, 18 - 20 Mart 2016, (Özet Bildiri)

28. Mapping of blood coagulation via image processing method Kan Pihtdaimasinin Görüntü Işleme Yöntemiyle Haritalandirilmasi

Onar B., Bayindir M., BİLGİLİ H., ERKURT M. A., Yakinci C., YAKINCI M. C.
Medical Technologies National Conference, TIPTEKNO 2015, Bodrum, Türkiye, 15 - 18 Ekim 2015, (Tam Metin Bildiri) identifier

29. Kadın Hastada Hemofili A

ÖZEN NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., DOLAŞIK İ., CÖMERT ÖZKAN M., et al.
10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

30. Deri Tutulumu İle Prezente Extranodal NHL Olgu Sunumu

KUM A., ERKURT M. A., NİZAM İ., BERBER İ., KAYA E., KUKU İ., et al.
10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

31. Akut Myeloid Lösemi Tanılı Hastada Nadir Bir Durum Fournier Gangreni

DOLAŞIK İ., ERKURT M. A., NİZAM ÖZEN İ., HİDAYET E., CÖMERT ÖZKAN M., KAYA E., et al.
10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

32. BÖBREK NAKLİ YAPILAN HASTALARDA ATİPİK HÜS DENEYİMİMİZ

KUM A., ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., et al.
10. AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015

33. Turgut Özal Tıp Merkezi Kemik İliği Nakli Merkezi nin 5 Yıllık Mobilizasyon Deneyimi

ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., DOLAŞIK İ., et al.
10. ULUSAL AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, ss.50

34. TROMBOTİK TROMBOSİTOPENİK PURPURA VE MYELONEKROZA NEDEN OLAN KARSİNOM

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ 41. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 21 - 24 Ekim 2015, ss.315

35. İMMÜN TROMBOSİTOPENİDE STEROİDE BAĞIMLI ELTROMBOPAG YANITI

NİZAM İ., KAYA E., BERBER İ., CÖMERT ÖZKAN M., ERKURT M. A., KUKU İ.
Türk Hematoloji Derneği 41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015, ss.175

36. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study

Tombak A., Tiftik N., Dogu M. H., Sari I., Akay M. O., Karagulle M., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri) identifier

37. UYGUN DONÖRLERDE ÜÇLÜ DOZ TROMBOSİT AFEREZİ DOĞU ANADOLU DAN TEK MERKEZ DENEYİMİ

ÖZGÜL M., ÖZEN İ. N., ERKURT M. A., KUKU İ., BERBER İ., DOLAŞIK İ., et al.
10.AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

38. Leukapheresis in elderly patients are safe and effective treatment

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., GÖZÜKARA BAĞ H. G., et al.
IX. Ulusal Aferez Kongresi, Kıbrıs (Kktc), 4 - 07 Eylül 2014, ss.177-178, (Özet Bildiri)

39. Bu Cy E Conditioning Regimen Can Be An Alternative Treatment to BEAM at Autologous Transplantation for Lymphoma

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KUKU İ.
IX. Ulusal Aferez Kongresi, Türkiye, 4 - 07 Eylül 2014

40. PRIMARY BREAST LYMPHOMA IN A MALE PATIENT

BERBER İ., ERKURT M. A., yiğit a., KAYA E., KUKU İ., KÖROĞLU M., et al.
IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Türkiye, 9 - 13 Ekim 2013, cilt.3, ss.129

41. CHRONIC MYELOİD LEUKEMIA PRESENTING A MAN WİTH A AT CHONDROPLASIA A RARE CASEINTRODUCTlON

NİZAM İ., ERKURT M. A., KAYA E., KÖROĞLU M., BERBER İ., BENTLİ R., et al.
4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 Ekim 2013

42. KEMİK İLİĞİ İNCELEMESİ SONRASINDA NADİR BİR KOMPLİKASYON A V FİSTÜL

BERBER İ., ERKURT M. A., BAZNA S., KAYA E., NİZAM İ., KÖROĞLU M., et al.
8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.149-150

43. AKUT MYELOİD LÖSEMİDE CİLT MUAYENESİ VE ÖNEMİ

BERBER İ., ERKURT M. A., KAYA E., NİZAM İ., KUKU İ., KÖROĞLU M., et al.
8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

44. HEMATOLOJİ KONSÜLTASYONU İSTENEN HASTALARIN BÖLÜMLERE VE İSTEM NEDENLERİNE GÖRE DAĞILIMI

KÖROĞLU M., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 04 Kasım 2012

45. KEMİK İLİĞİ NAKİL MERKEZİ KÜLTÜR SONUÇLARIMIZ TEK MERKEZ DENEYİMİ

KÖROĞLU M., BERBER İ., KAYA E., ERKURT M. A., KUKU İ.
7. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 8 - 10 Mart 2012, ss.171, (Özet Bildiri)

46. Doğu Anadoluda bulunan merkezimizdeki lenfomalı hastaların tanı sırasındaki klinik özellikleri ve seyirleri

BAYDAR M., KUKU İ., KAYA E., DİKİLİTAŞ M., ATEŞ F., ERKURT M. A., et al.
Türk Hematoloji Derneği 29. Ulusal Kongresi, Antalya, Türkiye, 25 - 28 Ekim 2002

47. İdiopatik trombositopenik purpurada oral yüksek doz steroid tedavisi sonuçlarımız

KUKU İ., AYDOĞDU İ., KAYA E., BAYDAR M., DİKİLİTAŞ M., ATEŞ F., et al.
Türk Hematoloji Derneği 29. Ulusal Kongresi, Antalya, Türkiye, 25 - 28 Ekim 2002
Kitaplar 2

1. Tıp Dalları Tarihçesi

YAKINCI M. C., TANRIVERDİ L. H., ERKURT M. A., ALTUNTAŞ F., YİĞENOĞLU T. N.
Nobel Tıp Kitabevleri, İstanbul, 2023

2. KLİNİK HEMATOLOJİ ONKOLOJİ ATLASI

AYDOGDU İ., KAYA E., KUKU İ., ATEŞ F., ULU R., BAYDAR M., et al.
Sistem Sistem Ofset Basım Yayım, Ankara, 2004
Metrikler

Yayın

201

Yayın (WoS)

92

Yayın (Scopus)

88

Atıf (WoS)

366

H-İndeks (WoS)

10

Atıf (Scopus)

240

H-İndeks (Scopus)

8

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

18

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları